21/06/2024 Healthcare
Rabeprazole Injection IP, marketed as Satmorab-IV, is a potent intravenous medication used primarily for treating severe gastroesophageal reflux disease (GERD) and gastric ulcers. It belongs to the proton pump inhibitor class, effectively suppressing gastric acid secretion to alleviate symptoms such as heartburn and acid reflux. Satmorab-IV offers rapid onset of action, making it valuable in acute settings where oral therapy is not feasible. It ensures quick relief and management of acid-related gastrointestinal disorders.Available in PCD Franchise for injectable range and third party manufacturing.
We offer premium-grade lyophilized injection products, manufactured in GMP-certified facilities. Suitable for pharmaceutical and clinical applications...
Explore growth with OneKrit’s Injectable Range Franchise, your trusted partner in the pharma sector. We offer a high-quality injectable range, ensurin...
PCD Injectable Companies provide high-quality injections used for treating different health problems. These companies give business opportunities to p...
GaliDerm Aesthetics – Expert Non-Surgical Treatments Specializing in natural-looking cosmetic enhancements, GaliDerm Aesthetics offers: Attiva RF Skin...
More Details